ALFA Finder| Management target | Revenue 25.0% FY27 |
|---|
| Revenue growth | 59.1% YoY in Q1 FY27 |
|---|---|
| Margins | EBITDA margins expanded to 34.3% due to product mix |
| Demand visibility | Strong momentum in CDMO and Pharma Intermediates |
| Management confidence | Confident in 25% full-year growth |
Growth
Q1 FY27 Revenue rose 59.1% YoY to ₹3,297 Mn; EBITDA surged 122.1% and PAT grew 70.4% YoY.
Outlook
Management guides for 25% revenue growth for the full year with stable margins.
Risks
Muted performance in commodity chemicals segment and lower other income impacting PAT margins were noted.
Last quarter's promises, checked
Delivered
- Guided 25% revenue growth for FY27 → delivered 59.1% in Q1 (= BEAT)
- Guided EBITDA margin maintenance → delivered 34.3% vs 34.5% FY26 (= BEAT)
- Guided H1 contribution ~40% of top line → Q1 revenue ₹3,297 Mn on track (= BEAT)
Partly delivered
- Guided pilot plant completion by Q2 FY27 → construction ongoing (= PARTIAL)
- Guided electrolyte additive phase 2 completion Q1 FY27 → spillover capex remains (= PARTIAL)
Missed
- Guided BFC recovery to offset commodity weakness → Specialty Chemicals fell 10.6% (= MISS)
Investor Presentation filed with BSE, NSE: ACUTAAS. Summary written with AI assistance from the document.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹3,916.90
- Market cap
- ₹32,068 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 73.0×Sector 43.8×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Management Change
Acutaas Chemicals appointed Dr. Ashish Kumar Pandey as AVP Operations (Cluster Head, Units 2 & 3) and designated as SMP from November 2, 2026. Two existing GMs ceased to be SMP but continue in the company.
Acutaas Chemicals Earnings Call Transcript: Key Takeaways
Acutaas reports high-growth Q2 fueled by pharma intermediates and CDMO scaling, despite commodity chemical phase-outs.
- Call
- Guides 100% growth
Acutaas Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,369 Mn (+42.7% YoY), EBITDA ₹1,760 Mn (+84.6%, 40.3% margin), PAT ₹1,231 Mn (+71.4%). FY27 revenue guidance raised; South Korea semiconductor-chemicals facility inaugurated.
- Call
- Guides 30% growth
Acutaas Chemicals Results Update
Q2 FY27 revenue rose 42.7% YoY to ₹4,369 mn; PAT up 71.4% to ₹1,231 mn. Guidance raised to 30% revenue growth and 38-40% EBITDA margin.
Acutaas Chemicals Q2 FY27 Results: Net Profit ₹123.1 Cr, Up 71.2% YoY
Acutaas Chemicals Ltd reported revenue from operations of ₹436.9 Cr (+42.7% YoY) and net profit of ₹123.1 Cr (+71.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹123.1 Cr · +71.2% YoY
Acutaas Chemicals Financial Results
Acutaas Chemicals' board approved Q2 and half-year FY2027 unaudited results. The board meeting closed with no other material transaction disclosed.